Luiz Augusto Fanhani Cracco

Mr. Luiz Augusto Fanhani Cracco

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
SPSalma Ali El Chab Parolin
Salma Ali El Chab Parolin
RSRebecca Benicio Stocco
Rebecca Benicio Stocco
JLJulia Do Carmo Kneipp Lopes
Julia Do Carmo Kneipp Lopes
MPMarcos Roberto Curcio Pereira
Marcos Roberto Curcio Pereira
MYMilena Massae Yamashita
Milena Massae Yamashita
CBCristina Pellegrino Baena
Cristina Pellegrino Baena
Background: This study aimed to determine the association between glycemic variability (GV) and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods: We prospectively analyzed data from inpatients (> 18 years old) with RT-PCR confirmed COVID-19 admitted between March 2020 and July 2021. All patients were hospitalized for more than 48 h and had at least six point-of-care capillary glucose tests obtained three times daily in the pre-prandial period during hospitalization. GV was measured using the glucose standard deviation (SD) and coefficient of variation (CV). ROC curve was adjusted to determine the SD and CV cutoff values associated with mortality (44.7 mg/dL and 27.5%, respectively); values above these were considered indicative of high GV. Logistic regression models were fitted to explore the association between GV and mortality in patients with and without diabetes. Results: A total of 628 patients were stratified into SD < 44.7 mg/dL (n = 357) versus ≥ 44.7 mg/dL (n = 271) and CV < 27.5% (n = 318) versus ≥ 27.5% (n = 310) groups. After controlling for age, sex, presence of diabetes mellitus (DM) and cardiovascular disease, we found a significant association between high GV and mortality (odds ratio 2.99 [1.88–4.77] for SD and 2.43 [1.54–3.85] for CV; p values < 0.001). The mortality rate was higher with SD ≥ 44.7 mg/dL and CV ≥ 27.5% compared to that with SD < 44.7 mg/dL and CV < 27.5%, regardless of DM (p < 0.001 for all). Conclusion: High glycemic variability was independently associated with mortality in patients with and without DM, who were hospitalized with COVID-19.

27 April 2023 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
LNLarissa Hermann de Souza Nunes
Larissa Hermann de Souza Nunes
JLJoão Felipe Bernardi Lora
João Felipe Bernardi Lora
LCLuiz Augusto Fanhani Cracco
Luiz Augusto Fanhani Cracco
JMJanice Alexandra da Costa Manuel
Janice Alexandra da Costa Manuel
JCJune Alisson Westarb Cruz
June Alisson Westarb Cruz
FTFelipe Francisco Tuon
Felipe Francisco Tuon
Introduction: Pseudomonas aeruginosa respiratory infections are challenging, and the risk of recurrence is a frequent problem. The aim of this study was to investigate the risk factors associated with the presence of P. aeruginosa, and the risk factors related to the recurrence and death of lower airway infections in inpatients in a Brazilian hospital.Methods: Retrospective cohort with inpatients that had a sample of airways culture (tracheal aspirate or bronchoalveolar lavage) with the detection of P. aeruginosa. The patients with clinical criteria of infection were classified as ventilator‐associated, hospital‐acquired, or community‐acquired pneumonia. P. aeruginosa in respiratory samples without symptoms was considered colonization. The antimicrobial treatment adequacy and the clinical data were evaluated. Outcome variables included mortality and recurrence.Results: One hundred and fifty‐four patients were included in the study, most of them were men, and the majority (102) were considered infected. The average length of stay was superior to 30 days. Previous pulmonary disease was associated with the occurrence of colonization. Aminoglycosides were the most active drug according to susceptibility tests and were successfully used as monotherapy. Septic shock was a risk factor for death in the infected patients. The use of adequate antimicrobial therapy was associated with major survival, independent of the infection classification.Conclusion: It is possible to evaluate clinical data associated with recurrence and mortality in patients with different lung infections by P. aeruginosa. Aminoglycoside monotherapy is safe and effective in P. aeruginosa respiratory infections.

Verified
Journal Article
Open access
PDF file
LBLeonardo Vinicius Barbosa
Leonardo Vinicius Barbosa
DPDaniele Margarita Marani Prá
Daniele Margarita Marani Prá
SNSeigo Nagashima
Seigo Nagashima
MPMarcos Roberto Curcio Pereira
Marcos Roberto Curcio Pereira
RSRebecca Benicio Stocco
Rebecca Benicio Stocco
LNLucia de Noronha
Lucia de Noronha
The COVID-19 pandemic, promoted by the SARS-CoV-2 respiratory virus, has resulted in widespread global morbidity and mortality. The immune response against this pathogen has shown a thin line between protective effects and pathological reactions resulting from the massive release of cytokines and poor viral clearance. The latter is possibly caused by exhaustion, senescence, or both of TCD8+ cells and reduced activity of natural killer (NK) cells. The imbalance between innate and adaptive responses during the early stages of infection caused by SARS-CoV-2 contributes to the ineffective control of viral spread. The present study evaluated the tissue immunoexpression of the tissue biomarkers (Arginase-1, CCR4, CD3, CD4, CD8, CD20, CD57, CD68, CD138, IL-4, INF-α, INF-γ, iNOS, PD-1, Perforin and Sphingosine-1) to understand the cellular immune response triggered in patients who died of COVID-19. We evaluated twenty-four paraffin-embedded lung tissue samples from patients who died of COVID-19 (COVID-19 group) and compared them with ten lung tissue samples from patients who died of H1N1pdm09 (H1N1 group) with the immunohistochemical markers mentioned above. In addition, polymorphisms in the Perforin gene were genotyped through Real-Time PCR. Significantly increased tissue immunoexpression of Arginase, CD4, CD68, CD138, Perforin, Sphingosine-1, and IL-4 markers were observed in the COVID-19 group. A significantly lower immunoexpression of CD8 and CD57 was also found in this group. It is suggested that patients who died from COVID-19 had a poor cellular response concerning viral clearance and adaptive response going through tissue repair.

12 September 2022
Verified
Conference Paper
Open access
RBRoberta Zawadzki Bueno
Roberta Zawadzki Bueno
LCLuiz Augusto Fanhani Cracco
Luiz Augusto Fanhani Cracco
AOAfonso Gomes de Oliveira
Afonso Gomes de Oliveira
ALAndré Wilson de Lima Liveira
André Wilson de Lima Liveira
EPEduardo dos Santos Paiva
Eduardo dos Santos Paiva
GKGustavo Koíti Kondo
Gustavo Koíti Kondo

1 January 2023
Verified
Conference Paper
Closed access
LCLuiz Augusto Fanhani Cracco
Luiz Augusto Fanhani Cracco
MOMarian Hanae Oda
Marian Hanae Oda
GKGustavo Koíti Kondo
Gustavo Koíti Kondo
AOAfonso Gomes de Oliveira
Afonso Gomes de Oliveira
AKAugusto Luís Kienen
Augusto Luís Kienen
EPEduardo Santos Paiva
Eduardo Santos Paiva

7 January 2022 in Revista de Medicina da UFC
Verified
Journal Article
Open access
PDF file
LCLuiz Augusto Fanhani Cracco
Luiz Augusto Fanhani Cracco
ISIsabela Busto Silva
Isabela Busto Silva
EJEdson Marcos Campos Lessa Junior
Edson Marcos Campos Lessa Junior
GMGustavo Lenci Marques
Gustavo Lenci Marques
GVGiovanna Vinholi
Giovanna Vinholi
Objetivos: relatar a experiência do diagnóstico de amiloidose, uma doença de frequência incomum nos hospitais gerais, através de técnicas simples e acessíveis de coloração histológica. Metodologia: relatamos o caso de um paciente de 57 anos de idade, que foi admitido no departamento de emergência devido a complicações de hipertensão arterial sistêmica com evidências de doença de depósito, submetido à biópsia renal. Resultados: a análise histológica confirmou a presença de depósitos amiloides renais através da coloração cristal de violeta. Conclusões: técnicas histopatológicas simples e acessíveis são métodos viáveis para auxiliar no diagnóstico de amiloidose, uma doença de depósito infrequente em centros não especializados.